NCT04793555

Brief Summary

The progression of neurodegenerative disorders and the increasing number of elderly people intensifies the need of institutional care, which contrasts with the desire of most elderly and patients to live independently at home. The rapid evolution of assistive technology offers new possibilities in providing medical professionals preventive services in real-time. Therefore, the main focus of this study is on the individual sensors and how they can be combined to one unobtrusive system to assess the human behaviour and daily activities during day and night in an instrumented apartment in healthy participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

August 11, 2022

Status Verified

August 1, 2022

Enrollment Period

9 months

First QC Date

March 3, 2021

Last Update Submit

August 10, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Heart rate (Vital parameters)

    The heart rate will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

    1 Week / Continuously

  • Respiration rate (Vital parameters)

    The respiration rate will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

    1 Week / Continuously

  • Oxygen saturation (Vital parameters)

    The oxygen saturation will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

    1 Week / Continuously

  • Systolic / Diastolic blood pressure (Vital parameters)

    The blood pressure will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

    1 Week / Continuously

  • Skin conductance (Vital parameters)

    The skin conductance will be continuously measured by pressure sensors, radar sensors, infrared camera, galvanic sensor and polysomnography (gold standard).

    1 Week / Continuously

Secondary Outcomes (1)

  • 3D Model (Coordinates of the joints over time) of the participant in the apartment (Movement parameters)

    1 Week / Continuously

Other Outcomes (19)

  • Usability

    Each day / 7x

  • Doors open and closed (Activities of daily living)

    1 Week / Continuously

  • Power used - Power Plugs (Activities of daily living)

    1 Week / Continuously

  • +16 more other outcomes

Study Arms (1)

Experimental_Arm

EXPERIMENTAL

Assessment of behavior during day and night by unobtrusive sensors

Other: Monitoring by unobtrusive sensors

Interventions

During the study the behavior of daily activities will be monitored by unobstructive sensors. Most of the sensors will be mounted on the wall or on furniture with direct sight to the participant and thus will not have any physical contact, except some wearables during the stay in the apartment and at home (e.g. watch, mobile polysomnography).

Experimental_Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • Aged ≥18 years
  • German speaking

You may not qualify if:

  • Infected by multidrug-resistant bacteria according to current medical history
  • Incontinence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ARTORG Center for Biomedical Engineering, Gerontechnology and Rehabilitation

Bern, Ber, 3008, Switzerland

Location

Related Publications (5)

  • Andersen CK, Wittrup-Jensen KU, Lolk A, Andersen K, Kragh-Sorensen P. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004 Sep 21;2:52. doi: 10.1186/1477-7525-2-52.

    PMID: 15383148BACKGROUND
  • Saner H, Schutz N, Botros A, Urwyler P, Buluschek P, du Pasquier G, Nef T. Potential of Ambient Sensor Systems for Early Detection of Health Problems in Older Adults. Front Cardiovasc Med. 2020 Jul 15;7:110. doi: 10.3389/fcvm.2020.00110. eCollection 2020.

    PMID: 32760739BACKGROUND
  • Schutz N, Saner H, Rudin B, Botros A, Pais B, Santschi V, Buluschek P, Gatica-Perez D, Urwyler P, Marchal-Crespo L, Muri RM, Nef T. Validity of pervasive computing based continuous physical activity assessment in community-dwelling old and oldest-old. Sci Rep. 2019 Jul 4;9(1):9662. doi: 10.1038/s41598-019-45733-8.

    PMID: 31273234BACKGROUND
  • Urwyler P, Stucki R, Rampa L, Muri R, Mosimann UP, Nef T. Cognitive impairment categorized in community-dwelling older adults with and without dementia using in-home sensors that recognise activities of daily living. Sci Rep. 2017 Feb 8;7:42084. doi: 10.1038/srep42084.

    PMID: 28176828BACKGROUND
  • Wimo A, Jonsson L, Bond J, Prince M, Winblad B; Alzheimer Disease International. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013 Jan;9(1):1-11.e3. doi: 10.1016/j.jalz.2012.11.006.

    PMID: 23305821BACKGROUND

MeSH Terms

Conditions

Neurodegenerative Diseases

Condition Hierarchy (Ancestors)

Nervous System Diseases

Study Officials

  • Stephan M Gerber, PhD

    Gerontechnology & Rehabilitation Group, University of Bern, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Single-center prospective non-inferiority study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2021

First Posted

March 11, 2021

Study Start

June 1, 2021

Primary Completion

February 28, 2022

Study Completion

July 29, 2022

Last Updated

August 11, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Data will be available after the publication of the results upon request.

Locations